{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:38Z","timestamp":1787242298445,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2020\/01285-2"],"award-info":[{"award-number":["2020\/01285-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jsbmb.2025.106679","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:52:11Z","timestamp":1737463931000},"page":"106679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Signaling crosstalk of Galectin-3, \u03b2-catenin, and estrogen receptor in androgen-independent prostate cancer DU-145 cells"],"prefix":"10.1016","volume":"247","author":[{"given":"Deborah Sim\u00e3o","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Meloni","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Macheroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Leiria","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Segreti","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2025.106679_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.jsbmb.2025.106679_bib2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1080\/14656566.2018.1527312","article-title":"Advancing therapies in metastatic castration-resistant prostate cancer","volume":"19","author":"Baciarello","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jsbmb.2025.106679_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CCO.0000000000000520","article-title":"Targeting the androgen receptor and overcoming resistance in prostate cancer","volume":"31","author":"Einstein","year":"2019","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib4","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jsbmb.2025.106679_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc3647","article-title":"Beyond E-cadherin: roles of other cadherin superfamily members in cancer","volume":"14","author":"van Roy","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2025.106679_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2005.06.004","article-title":"Roles and regulation of Wnt signaling and beta-catenin in prostate cancer","volume":"237","author":"Verras","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2025.106679_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","article-title":"WNT signalling in prostate cancer","volume":"14","author":"Murillo-Garz\u00f3n","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12672-021-00433-6","article-title":"Wnt\/\u03b2-catenin signal transduction pathway in prostate cancer and associated drug resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/mmr.2016.6067","article-title":"Short hairpin RNA directed against \u03b2-catenin inhibits prostate cancer growth and invasion in vitro","volume":"15","author":"Zhao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jsbmb.2025.106679_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2018.01.008","article-title":"Activation of Estrogen Receptor beta (ER\u03b2) regulates the expression of N-cadherin, E-cadherin and \u03b2-catenin in androgen-independent prostate cancer cells","volume":"96","author":"Silva","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2016.04.012","article-title":"Estrogen receptor beta (ER\u03b2) mediates expression of \u03b2-catenin and proliferation in prostate cancer cell line PC-3","volume":"430","author":"Lombardi","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/ijms22031153","article-title":"Estrogen Receptor signaling pathways involved in invasion and colony formation of androgen-independent prostate cancer cells PC-3","volume":"22","author":"Lombardi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106679_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/er.2003-0034","article-title":"Interaction of nuclear receptors with the Wnt\/beta-catenin\/TCF signaling axis: Wnt you like to know?","volume":"26","author":"Mulholland","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2025.106679_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcb.20983","article-title":"Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer","volume":"99","author":"Terry","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jsbmb.2025.106679_bib15","article-title":"Divergent androgen receptor and beta-catenin signaling in prostate cancer cells","volume":"10","author":"Lee","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jsbmb.2025.106679_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2017.02.008","article-title":"Revisiting the role of Wnt\/\u03b2-catenin signaling in prostate cancer","volume":"462","author":"Schneider","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fendo.2020.00184","article-title":"Estrogen Receptors promote migration, invasion, and colony formation of the androgen-independent prostate cancer cells PC-3 through \u03b2-Catenin pathway","volume":"11","author":"Lombardi","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib18","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2353\/ajpath.2008.080380","article-title":"Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry","volume":"173","author":"Mourad-Zeidan","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5483\/BMBRep.2020.53.4.020","article-title":"Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner","volume":"53","author":"Kim","year":"2020","journal-title":"BMB Rep."},{"key":"10.1016\/j.jsbmb.2025.106679_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1124111","article-title":"Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor","volume":"14","author":"Souza","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/or.2023.8530","article-title":"Estrogen receptors regulate galectin\u20113 in androgen\u2011independent DU\u2011145 prostate cancer cells","volume":"49","author":"Souza","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jsbmb.2025.106679_bib22","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1158\/0008-5472.CAN-04-1816","article-title":"Galectin-3, a novel binding partner of beta-catenin","volume":"64","author":"Shimura","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2025.106679_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2018.12.015","article-title":"Estrogen receptors localization and signaling pathways in DU-145 human prostate cancer cells","volume":"483","author":"Souza","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib24","article-title":"Multi layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2 catenin signaling activation (Review)","author":"Katoh","year":"2018","journal-title":"Int. J. Med. 42, 713-725"},{"key":"10.1016\/j.jsbmb.2025.106679_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/1541-7786.MCR-14-0372","article-title":"Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases","volume":"13","author":"Vicente","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jsbmb.2025.106679_bib26","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1021\/jm000170m","article-title":"Pyrazole ligands: structure-affinity\/activity relationships and estrogen receptor-alpha-selective agonists","volume":"43","author":"Stauffer","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106679_bib27","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/jm010254a","article-title":"Estrogen Receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues","volume":"44","author":"Meyers","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106679_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.steroids.2015.12.021","article-title":"Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells","volume":"107","author":"Pisolato","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106679_bib29","doi-asserted-by":"crossref","first-page":"T219","DOI":"10.1530\/ERC-13-0508","article-title":"Estrogen receptor beta in prostate cancer: friend or foe?","volume":"21","author":"Nelson","year":"2014","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2025.106679_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2025.106679_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2018.00002","article-title":"Estrogens and their receptors in prostate cancer: therapeutic Implications","volume":"8","author":"Di Zazzo","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2025.106679_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphys.2011.00030","article-title":"The Effects of 17\u03b2-estradiol in cancer are mediated by Estrogen Receptor signaling at the plasma membrane","volume":"2","author":"Acconcia","year":"2011","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab041","article-title":"Membrane-initiated estrogen, androgen, and Progesterone Receptor signaling in health and disease","volume":"43","author":"Mauvais-Jarvis","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2025.106679_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/abbi.1997.0447","article-title":"The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter","volume":"349","author":"Kadrofske","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2025.106679_bib36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2025.106679_bib37","doi-asserted-by":"crossref","first-page":"15594","DOI":"10.18632\/oncotarget.3709","article-title":"PBK\/TOPK enhances aggressive phenotype in prostate cancer via \u03b2-catenin-TCF\/LEF-mediated matrix metalloproteinases production and invasion","volume":"6","author":"Brown-Clay","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2025.106679_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2018.08.019","article-title":"NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells","volume":"294","author":"Gu","year":"2018","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.jsbmb.2025.106679_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adi7861","article-title":"A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells","volume":"17","author":"Kalyanaraman","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jsbmb.2025.106679_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106679_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155134","article-title":"The emerging role of non-coding RNAs in the Wnt\/\u03b2-catenin signaling pathway in Prostate Cancer","volume":"254","author":"Kazmi","year":"2024","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.jsbmb.2025.106679_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","article-title":"Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2025.106679_bib43","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-05-0104","article-title":"Implication of Galectin-3 in Wnt signaling","volume":"65","author":"Shimura","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2025.106679_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","volume":"2017","author":"Mancinelli","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jsbmb.2025.106679_bib45","article-title":"Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression","volume":"138","author":"Kim","year":"2010","journal-title":"Gastroenterology"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:24:15Z","timestamp":1778783055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007602500007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":45,"alternative-id":["S096007602500007X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106679","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling crosstalk of Galectin-3, \u03b2-catenin, and estrogen receptor in androgen-independent prostate cancer DU-145 cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106679"}}